Clinical Research Groups
Emergency and intensive care biomarkers
The GRC-14 BIOSFAST is dedicated to the study of emergency and intensive care biomarkers, and particularly the validation of their clinical usefulness and added-value, either for the diagnosis or the risk-stratification. The GRC-14 offers its expertise in several fields including infection and sepsis, head trauma, cardiac biomarkers, stress biomarkers, particularly through its 3 adult emergency departments, to design and conduct clinical trials in order to validate already marketed biomarkers but also upcoming R&D biomarkers.
- Institut National de la Santé et de la Recherche Médicale | INSERM